-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Epigenetic Reprogramming to Sensitize Immunologically Silent EBV+ Lymphomas

Scientific Workshop on Viruses in Hematology: Emerging Challenges and Therapeutic Vulnerabilities
Program: Scientific Workshops
Session: Emerging Vulnerabilities in Special Populations
Friday, December 8, 2023, 2:43 PM-3:33 PM

Lisa Giulino Roth, MD

Weill Cornell Medical College, New York, NY

Disclosures: Roth: Merck: Consultancy, Membership on an entity's Board of Directors or advisory committees; Roche: Consultancy, Membership on an entity's Board of Directors or advisory committees.

<< Previous Presentation | Next Presentation